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Abstract 72 
An epidemiological paradox surrounds Salmonella enterica serovar Enteritidis. In 73 
high-income settings, it has been responsible for an epidemic of poultry-associated, 74 
self-limiting enterocolitis, whilst in sub-Saharan Africa it is a major cause of invasive 75 
nontyphoidal Salmonella disease, associated with high case-fatality. Whole-genome 76 
sequence analysis of 675 isolates of S. Enteritidis from 45 countries reveals the 77 
existence of a global epidemic clade and two novel clades of S. Enteritidis that are 78 
each geographically restricted to distinct regions of Africa. The African isolates 79 
display genomic degradation, a novel prophage repertoire and have an expanded, 80 
multidrug resistance plasmid. S. Enteritidis is a further example of a Salmonella 81 
serotype that displays niche plasticity, with distinct clades that enable it to become a 82 
prominent cause of gastroenteritis in association with the industrial production of 83 
eggs, and of multidrug resistant, bloodstream invasive infection in Africa.  84 
  85 
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Introduction 86 
 87 
Salmonella enterica serovar Enteritidis (hereafter referred to as S. Enteritidis) has 88 
been a global cause of major epidemics of enterocolitis, which have been strongly 89 
associated with intensive poultry farming and egg production [1]. The serovar is 90 
usually considered to be a generalist in terms of host range and has a low human 91 
invasiveness index, typically causing self-limiting enterocolitis [2]. Following a 92 
number of interventions in the farming industry involving both improved hygiene 93 
and poultry vaccination, epidemic S. Enteritidis has been in decline in many 94 
countries including the United Kingdom and USA [3,4]. S. Enteritidis has also been 95 
used extensively since the early 1900s as a rodenticide (named the “Danysz virus”), 96 
following development at Institut Pasteur, France. Although by the 1960s, 97 
Salmonella-based rodenticides had been banned in the US, Germany and the UK, S. 98 
Enteritidis is still produced as a rodenticide in Cuba, under the name Biorat®[5]. 99 
 100 
Serovars of Salmonella that cause enterocolitis in industrialised settings are strongly 101 
associated with life-threatening invasive nontyphoidal Salmonella (iNTS) disease in 102 
sub-Saharan Africa (SSA). S. Enteritidis and Salmonella enterica serovar 103 
Typhimurium (S. Typhimurium) are the two leading causes of iNTS disease in SSA 104 
[6] and both are associated with multidrug resistance (MDR)[7]. The clinical 105 
syndrome iNTS disease is associated with immunosuppression in the human host, 106 
particularly malnutrition, severe malaria and advanced HIV in young children and 107 
advanced HIV in adults [8]. It has been estimated to cause 681,000 deaths per year 108 
[9].  109 
 110 
Salmonella is a key example of a bacterial genus in which there is a recognizable 111 
genomic signature that distinguishes between a gastrointestinal and an extra-112 
intestinal/invasive lifestyle [10], whereby functions required for escalating growth 113 
in an inflamed gut are lost when the lineage becomes invasive [11]. In order to 114 
investigate whether there were distinct bacterial characteristics explaining the very 115 
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different epidemiological and clinical profile of epidemic isolates of serotype S. 116 
Typhimurium from SSA and industrialised settings, whole-genome sequence (WGS) 117 
investigations of this serovar were previously undertaken. These revealed a novel 118 
pathotype of multilocus sequence type (MLST) ST313 from SSA, which differed from 119 
clades that cause enterocolitis in industrialised settings, by showing patterns of 120 
genomic degradation potentially associated with more invasive disease and 121 
differential host adaptation [12-17]. 122 
 123 
In relation to S. Enteritidis, there is a growing body of literature on the evolutionary 124 
history, phylogeny and utility of WGS for surveillance of S. Enteritidis outbreaks [18-125 
20]. The broadest study of the phylogeny to date revealed five major lineages, but 126 
contained only two African isolates [21]. There have also been limited reports of 127 
isolates of S. Enteritidis from African patients living in Europe that are MDR and 128 
which display a distinct phage type (PT 42) [22,23]. We therefore hypothesized that 129 
there are distinct lineages of S. Enteritidis circulating in both the industrialised and 130 
developing world with different origins, likely distinct routes of spread and that are 131 
associated with different patterns of disease, which will display the distinct genomic 132 
signatures characteristic of differential adaptation. To investigate this we have 133 
collected a highly diverse global collection of S. Enteritidis isolates and compared 134 
them using whole-genome sequencing, the highest possible resolution typing 135 
methodology. 136 
 137 
 138 
 139 
 140 
 141 
 142 
 143 
  144 
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Results 145 
 146 
Isolate collection 147 
 148 
In total, 675 isolates of S. Enteritidis isolated between 1948 and 2013 were 149 
sequenced. The collection originated from 45 countries and six continents (Table 1). 150 
496/675 isolates were from Africa, with 131 from the Republic of South Africa 151 
(RSA), a further 353 from the rest of SSA, and 12 from North Africa (Table 1). There 152 
were 343 isolates from normally sterile human sites (invasive), 124 non-invasive 153 
human isolates (predominantly stool samples) and 40 from animal, food or 154 
environmental sources. The full metadata are described in Supplementary Table 1 155 
and have been uploaded to the publically available database Enterobase  156 
(https://enterobase.warwick.ac.uk/). 157 
 158 
Phylogeny  159 
 160 
675 S. Enteritidis genomes and one Salmonella enterica serovar Gallinarum were 161 
mapped to the S. Enteritidis strain P125109 reference sequence, variable regions 162 
excluded and the remaining sites were screened for single nucleotide 163 
polymorphisms (SNPs). This left an alignment containing a total of 42,373 variable 164 
sites, from which a maximum likelihood (ML)-phylogeny was constructed using S. 165 
Gallinarum, which is a closely related serovar, as an out-group (Figure 1). HierBAPS 166 
was run over two rounds, which provided clear distinction between clades/clusters 167 
[24]. The phylogeny of S. Enteritidis revealed evidence of three clades associated 168 
with epidemics, one which we have termed the ‘global epidemic clade’ and includes 169 
the reference PT4 isolate P125109 and two African clades: one predominantly 170 
composed of West African isolates (labeled the ‘West African clade’) and a second 171 
composed of isolates predominantly originating in Central and Eastern Africa, called 172 
the ‘Central/Eastern African clade’). Figure 1 also shows the other clades and 173 
clusters predicted by HierBAPS, the largest of which is a paraphyletic cluster from 174 
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which the global epidemic clade emerged (Outlier Cluster in Figure 1), and a further 175 
five smaller clades or clusters predicted by HierBAPS. 176 
 177 
The global epidemic clade contains isolates of multiple phage types, including 4 and 178 
1, which have been linked to the global epidemic of poultry associated human 179 
enterocolitis [25]. It comprised 250 isolates from 28 countries, including 43 from 180 
Malawi and 82 from RSA. They were isolated from across a 63-year period (1948-181 
2013). Antimicrobial susceptibility testing had been performed on 144 isolates and 182 
104 were susceptible to all antimicrobials tested, five were multidrug resistant 183 
(MDR: resistant to 3 or more antimicrobial classes), one was nalidixic acid resistant 184 
and none were extended-spectrum beta-lactamase (ESBL)-producing isolates. 185 
Database comparison of the genomes from this clade revealed that 221 (88%) of 186 
them contained no predicted antimicrobial resistance (AMR) genes apart from the 187 
cryptic resistance gene aac(6')-Iy [26]. 188 
 189 
The global epidemic clade has emerged from a diverse cluster previously described 190 
by Zheng [27], which encompassed 131 isolates (Figure 1: ‘Outlier Cluster’). In 191 
addition to being paraphyletic, this group was geographically and temporally 192 
diverse, and predominantly drug susceptible (59/71 isolates). Whilst the majority of 193 
the diversity of phage typed isolates was contained within the global epidemic clade, 194 
this cluster alone contained isolates of phage type 14b, which was recently 195 
associated with a multi-country outbreak of S. Enteritidis enterocolitis in Europe 196 
associated with chicken eggs from Germany [28]. There were also 41 isolates from 197 
RSA in this clade, where it has been a common cause of bloodstream infection, and 198 
39 bloodstream isolates from Malawi. Database comparison of the genomes from 199 
this clade revealed that 122 (82%) of these genomes contained no predicted AMR 200 
genes apart from the cryptic resistance gene aac(6')-Iy. 201 
 202 
There were two related, but phylogenetically and geographically distinct, epidemic 203 
clades that largely originated from SSA. The Central/Eastern African clade included 204 
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166 isolates, all but two of which (from RSA) came from this region. Of these, 205 
126/155 (82%) were MDR and 148/153 (97%) displayed phenotypic resistance to 206 
between one and four antimicrobial classes. All of these genomes contained at least 207 
five predicted resistance genes and 128 (77%) contained nine (Table 2 and 208 
Supplementary Table 2). 155/165 (94%) of these isolates were cultured from a 209 
normally sterile compartment of a human (i.e. blood or cerebrospinal fluid) and 210 
were considered to be causing invasive disease (Table 2). The second African 211 
epidemic clade was significantly associated with West Africa with 65/66 isolates 212 
coming from this region and one isolate from USA. This clade was also associated 213 
with drug resistance (62 [94%] resistant to ≥1 antimicrobial class by phenotype and 214 
genotype) and human invasive disease (61 [92%]). It also included two isolates that 215 
were subtyped as phage type 4. 216 
 217 
The remaining 58 isolates included in this study were extremely diverse, 218 
phylogenetically, temporally and geographically. Only two displayed any phenotypic 219 
AMR, one of which was MDR. Inspection of the genome revealed that five had 220 
predicted AMR genes in addition to aac(6')-Iy, four of which were isolated in sub-221 
Saharan Africa. Twenty were associated with invasive human disease, and six were 222 
recovered from stool. Three isolates were from stocks of rodenticide and these were 223 
phylogenetically remote from both global-epidemic and the two African epidemic 224 
clades.  225 
 226 
To add further context to these findings we screened the entire publically available 227 
Public Health England (PHE) sequenced Salmonella routine surveillance collection, 228 
which includes 2,986 S. Enteritidis genomes, 265 of which were associated with 229 
travel to Africa (Supplementary Figure 1). Within this huge collection, including 61 230 
(2.0%) bloodstream isolates and 2670 (89.4%) stool isolates, only 6 isolates (4 from 231 
blood culture, 1 from stool) fell within to the West African clade and 1 (from stool) 232 
belonged to the Central/Eastern African clade. Notably, these isolates were all either 233 
associated with travel to Africa and/or taken from patients of African origin.  234 
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It is apparent from the location of the archetypal reference isolate and archetypal 235 
phage types in the phylogeny (Supplementary Figure 2) that the majority of S. 236 
Enteritidis studied previously belonged to the global epidemic clade associated with 237 
enterocolitis in industrialised countries. Furthermore, its also clear that two 238 
additional, previously unrecognized S. Enteritidis lineages have emerged, largely 239 
restricted to Africa, that are strongly associated with MDR and invasive disease.  240 
 241 
To understand how recently these African-associated lineages emerged we used 242 
Bayesian Evolutionary Analysis by Sampling Trees (BEAST) to reconstruct the 243 
temporal history of the epidemic clades [29]. These data (Supplementary Figure 3) 244 
estimate the most recent common ancestor (MRCA) of the Central/Eastern African 245 
clade dates to 1945 (95% Credible Interval [CrI]: 1924-1951) and for the West 246 
African clade it was 1933 (95% CrI: 1901-1956). We estimate the MRCA of the 247 
global epidemic clade originated around 1918 (95% CrI: 1879-1942 – 248 
Supplementary Figure 4), with a modern expansion occurring in 1976 (95% CrI: 249 
1968-1983), whereas the paraphyletic cluster from which it emerged dates to 250 
approximately 1711 (95% CrI: 1420-1868). 251 
 252 
The contribution of the accessory genome to the emergence of the African 253 
clades 254 
 255 
Prophages have the potential to carry non-essential "cargo" genes, which suggests 256 
they confer a level of specialization to their host bacterial species, whilst plasmids 257 
may confer a diverse array of virulence factors and AMR [30,31]. Therefore it is 258 
critical to evaluate the accessory genome in parallel with the core. 622 sequenced 259 
genomes were used to determine a pangenome, which yielded a core genome 260 
comprising 4,076 predicted genes present in ≥90% isolates, including all 12 261 
recognised Salmonella Pathogenicity Islands as well as all 13 fimbrial operons found 262 
in the P125109 reference [32]. The core gene definition was set to minimize 263 
stochastic loss of genes from the core due to errors in individual assemblies across 264 
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such a large dataset. The accessory genome consisted of 14,015 predicted genes. Of 265 
the accessory genes, 324 were highly conserved across the global and two African 266 
epidemic clades, as well as the outlier cluster. Almost all were associated with the 267 
acquisition or loss of mobile genetic elements (MGEs) such as prophage or plasmids. 268 
Prophage regions have been shown to be stable in Salmonella genomes and are 269 
potential molecular markers, the presence of which has previously been used to 270 
distinguish specific clades [13,33]. 271 
 272 
The lineage-specific whole gene differences of the major clades are summarized in 273 
Figure 2 and plotted against the representatives of the four major clades in 274 
Supplementary Figure 3. The lineage specific sequence regions include 57 predicted 275 
genes found to be unique to the global epidemic clade (Figure 2), all of which were 276 
associated with prophage ϕSE20, a region shown to be essential for invasion of 277 
chicken ova and mice in one previous study [34]. There were a further 39 genes 278 
conserved in the global epidemic and the paraphyletic outlying cluster, which were 279 
absent from both African clades, 26 of which correspond to region of difference 280 
(ROD) 21 [32]. The Central/Eastern Africa clade contained 77 predicted genes that 281 
were absent in the other clades. 33 were associated with the virulence plasmid and 282 
a further 40 chromosomal genes were associated with a novel, Fels-2 like prophage 283 
region (fels-BT). The West African clade had only 15 distinct predicted genes, 11 of 284 
which were plasmid-associated. The two African clades shared a further 102 genes: 285 
48, including a leucine-rich repeat region, were associated with a novel prophage 286 
region closely related to Enterobacter phage P88, 44 were associated with a Gifsy-1 287 
prophage found in S. Bovismorbificans and eight were associated with a Gifsy-2 288 
prophage which has degenerated in the reference P125109.  289 
 290 
The S. Enteritidis plasmid is the smallest of the generic Salmonella virulence 291 
plasmids at 58 kb and is unusual in that it contains an incomplete set of tra genes 292 
that are responsible for conjugative gene transfer. The phylogeny of the S. 293 
Enteritidis virulence plasmid backbone was reconstructed using reads that mapped 294 
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to the S. Enteritidis reference virulence plasmid, pSENV. 120/675 (18%) genomes 295 
lacked pSENV. The virulence plasmid phylogeny is similar to that of the 296 
chromosome, suggesting that they have been stably maintained by each lineage and 297 
diversified alongside them (Supplementary Figure 6).  298 
 299 
The virulence plasmids from the African clades were much larger than those held in 300 
the other clades at ~90 kb. A representative example was extracted from Malawian 301 
isolate D7795, sequenced using long read technology to accurately reconstruct it 302 
(PacBio; see methods) and denoted pSEN-BT (Accession number LN879484). pSEN-303 
BT is composed of a backbone of pSENV with additional regions that are highly 304 
similar to recently sequenced fragments of an novel S. Enteritidis virulence plasmid 305 
(pUO-SeVR) isolated from an African patient presenting with MDR invasive S. 306 
Enteritidis in Spain [22]. Plasmid pSEN-BT harbours nine AMR genes (full list in 307 
Supplementary Table 2), plus additional genes associated with virulence and a 308 
toxin/antitoxin plasmid addiction system. Of note, plasmids from the West African 309 
isolates carry resistance gene chloramphenicol acetyl transferase A1 (catA1), 310 
whereas the Central/Eastern African strains carry catA2 and tetracycline resistance 311 
gene tet(A). Like pSENV, the African virulence plasmid contained an incomplete set 312 
of tra genes and so is not self-transmissible. This was confirmed by conjugation 313 
experiments and is consistent with previous reports [22,23]. These observations 314 
suggest that the evolution of the S. Enteritidis plasmid mirrors that of the 315 
chromosome; it is thus not a ‘novel’ plasmid, but in different SSA locations has 316 
acquired different AMR genes. 317 
 318 
Multiple signatures of differential host adaptation 319 
 320 
It has been observed in multiple serovars of Salmonella including S. Typhi, S. 321 
Gallinarum and S. Typhimurium ST313 that the degradation of genes necessary for 322 
the utilization of inflammation-derived nutrients is a marker of that lineage having 323 
moved from an intestinal to a more invasive lifestyle [13,14,32,35]. Accordingly, we 324 
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have looked for similar evidence within a representative example of a MDR, 325 
invasive, Central/Eastern African clade isolate, D7795, that was isolated from the 326 
blood of a Malawian child in 2000. The draft genome sequence of D7795 closely 327 
resembles that of P125109, however, in addition to the novel prophage repertoire 328 
and plasmid genes described above, it harbours a number of predicted pseudogenes 329 
or hypothetically disrupted genes (HDGs)[11].  330 
 331 
In total, there were 42 putative HDGs in D7795, many of which are found in genes 332 
involved in gut colonisation and fecal shedding as well as various metabolic 333 
processes such as cobalamine biosynthesis which is a cofactor for anaerobic 334 
catabolism of inflammation-derived nutrients, such as ethanolamine, following 335 
infection [36]. Curation of the SNPs and insertions or deletions (indels) predicted to 336 
be responsible for pseudogenisation across the Central/Eastern African clade and 337 
West African clade revealed 37/42 predicted HDGs were fixed in other 338 
representatives of the Central/East African clade, with 27 of them being present in 339 
over 90% of isolates from that clade. Relatively fewer HDGs in D7795 (19/42) were 340 
present in representatives of the West African clade, although 13 were present in 341 
≥90% of isolates (Supplementary Table 3).   342 
 343 
In addition to this evidence of reductive evolution in D7795, there were 363 genes 344 
containing non-synonymous (NS)-SNPs, which change the amino acid sequence and 345 
so may have functional consequences [37]. The two African clades were screened 346 
for the presence of these NS-SNPs and 131 were found to be present and completely 347 
conserved across both clades, including NS-SNPs in 43 genes encoding predicted 348 
membrane proteins, 36 metabolic genes and 23 conserved hypothetical genes 349 
(Supplementary Table 4). Furthermore many of these NS-SNPs fall in genes within 350 
the same metabolic pathways as the HDGs (see Supplementary Results for detailed 351 
description).  Supplementary Table 5 provides a list of some of the common traits 352 
identified amongst the functions of genes lost independently by D7795, S. Typhi and 353 
S. Gallinarum. The disproportionate clustering of mutations in membrane structures 354 
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observed in the African clades is yet another sign of differential host adaptation 355 
analogous to that reported in both S. Typhi [35] and S. Gallinarum [32].  356 
 357 
BiologTM growth substrate platform profiling 358 
 359 
The BiologTM platform was utilized to generate a substrate growth utilisation profile 360 
for selected S. Enteritidis isolates (see high throughput phenotyping protocol in 361 
Supplementary materials). Corresponding signal values of replicate pairs of a 362 
Central/Eastern African isolate (D7795) and a global epidemic isolate (A1636) were 363 
compared using principal component analysis and found to be highly consistent. In 364 
total, 80 metabolites showed evidence of differential metabolic activity (Figure 3). 365 
Evaluation of data from the Central/Eastern African isolate using Pathway Tools 366 
software revealed that 14/27 (52%) of pathways with evidence of decreased 367 
metabolic activity at 28˚C had a corresponding component of genomic degradation. 368 
This was also true for 12/30 (40%) of pathways with evidence of decreased 369 
metabolic activity at 37oC.  370 
 371 
Instances of reduced metabolic activity in a Central/Eastern African strain (D7795) 372 
compared to a global epidemic strain (A1636) included dulcitol and glycolic acid in 373 
the glycerol degradation pathway, propionic acid in the propanediol pathway and 374 
ethylamine and ethanolamine. These are all vitamin B12 (cobalamin) dependent 375 
reactions, for which there was a corresponding signature of genomic degradation. 376 
Also there was reduced activity in response to three forms of butyric acid, alloxan 377 
and allantoic acid metabolism. Allantoin can be found in the serum of birds, but not 378 
humans and is utilised as a carbon source during S. Enteritidis infection of chickens, 379 
[38] and HDGs relating to allantoin have been noted in S. Typhimurium ST313 [13]. 380 
The full list of differences is detailed in Supplementary Table 6 and 7. This is a 381 
further sign of decreased metabolism of the Central/Eastern African isolate in the 382 
anaerobic environment of the gut.  383 
 384 
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Chicken infection model suggests evolutionary divide in host range between 385 
global epidemic and African lineages 386 
 387 
Given the phenotypic differences observed in the genotypically distinct global and 388 
African clades, we hypothesized that these lineages could have differing infection 389 
phenotypes in an in vivo challenge model. We compared the infection profile of a 390 
member of the Central/Eastern African clade (D7795) to the reference global 391 
epidemic strain P125109 in an avian host. The chicken group infected with P125109 392 
showed mild hepatosplenomegaly consistent with infection by this Salmonella 393 
serovar and cecal colonization (Figure 4A-C). In contrast, the Central/Eastern 394 
African strain displayed significantly reduced invasion at 7 dpi of both liver 395 
(p=0.027) and spleen (p=0.007), however cecal colonization was not significantly 396 
reduced (p=0.160). This is in marked contrast to the behavior of S. Typhimurium 397 
ST313, which is more invasive in a chick infection model [12].  398 
 399 
 400 
Discussion 401 
 402 
S. Enteritidis is an example of a successful Salmonella lineage with the apparent 403 
ability to adapt to different hosts and transmission niches as and when 404 
opportunities for specialization have presented. Langridge et al recently evaluated 405 
the Enteritidis/Gallinarum/Dublin lineage of Salmonella, revealing components of 406 
the nature and order of events associated with host-range and restriction [39]. In 407 
the present study, we have highlighted the plasticity of S. Enteritidis, providing 408 
evidence of three distinct epidemics of human disease. In addition we show multiple 409 
additional clades and clusters that demonstrate the huge reservoir of diversity 410 
amongst S. Enteritidis from which future epidemics might emerge.  411 
 412 
An important question posed by this study is why have distinct clades of Salmonella 413 
emerged to become prominent causes of iNTS disease in Africa, from a serotype 414 
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normally considered to be weakly invasive? The presence of a highly 415 
immunosuppressed population due to the HIV pandemic is clearly a key host factor 416 
that facilitates the clinical syndrome iNTS disease [40,41]. In addition to human host 417 
factors, there are two distinct African epidemic lineages that have emerged in the 418 
last 90 years. Both lineages are significantly associated with a novel prophage 419 
repertoire, an expanded, MDR-augmented virulence plasmid, and patterns of 420 
genomic degradation with similarity to other host-restricted invasive Salmonella 421 
serotypes including S. Typhi and S. Gallinarum and to clades of S. Typhimurium 422 
associated with invasive disease in Africa [13,32,35]. This pattern of genomic 423 
degradation is concentrated in pathways specifically associated with an enteric 424 
lifestyle, however it is noteworthy that in the chick infection model, the African S. 425 
Enteritidis invaded the chick liver and spleen less well than the global pandemic 426 
clade. This raises the possibility that the two clades occupy different ecological 427 
niches outside the human host or that they behave differently within the human 428 
host and screening of the huge S. Enteritidis collection from routine Salmonella 429 
surveillance by PHE supports the assertion that these lineages are geographically 430 
restricted to Africa. This study therefore indicates a need to understand what these 431 
ecological niches might be, and then to define the transmission pathways of African 432 
clades of S. Enteritidis, in order to facilitate public health interventions to prevent 433 
iNTS disease. 434 
 435 
The evolution of the S. Enteritidis virulence plasmid is intriguing; pSENV is the 436 
smallest of the known Salmonella virulence-associated plasmids, but in SSA, the 437 
plasmid has nearly doubled in size partly through the acquisition of AMR genes. The 438 
absence of tra genes necessary for conjugal transfer either indicates that MDR status 439 
has evolved through acquisition of MGEs multiple times or through clonal expansion 440 
and vertical transmission of the plasmid to progeny. The available data suggest that 441 
the former scenario has happened twice, once in West Africa, and once in 442 
Central/Eastern Africa.  443 
 444 
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Despite S. Enteritidis being reported as a common cause of bloodstream infection 445 
(BSI) in Africa [6,7] the Global Enteric Multicenter Study (GEMS) found that 446 
Salmonella serotypes were an uncommon cause of moderate to severe diarrhoea in 447 
African children less than 5-years of age [42]. Our data associating the African 448 
lineages with invasive disease is also consistent with data presented in a recent 449 
Kenyan study comparing a limited number and diversity of S. Enteritidis isolates 450 
from blood and stool. Applying the lineages defined in this study to the genome data 451 
reported from Kenya showed that 20.4% of isolates from that study belonging to the 452 
global clade were associated with invasive disease, whereas 63.2% of the isolates in 453 
that study belonging to our Central/Eastern African clade were associated with 454 
invasive disease [43]. The remaining isolates were associated with cases of 455 
enterocolitis or asymptomatic carriage, confirming that the Central/Eastern African 456 
clade can also cause enterocolitis. The association of S. Enteritidis clades circulating 457 
in sub-Saharan Africa with iNTS disease may reflect the fact that their geographical 458 
distribution permits them to behave as opportunistic invasive pathogens in a setting 459 
where advanced immunosuppressive disease is highly prevalent in human 460 
populations.  461 
 462 
In summary, two clades of S. Enteritidis have emerged in Africa, which have 463 
different phenotypes and genotypes to the strains of S. Enteritidis circulating in the 464 
industrial world. These strains display evidence of changing host adaptation, 465 
different virulence determinants and multi-drug resistance, a parallel situation to 466 
the evolutionary history of S. Typhimurium ST313. They may have different 467 
ecologies and/or host ranges to global strains and have caused epidemics of BSI in 468 
at least three countries in SSA, yet are rarely responsible for disease in South Africa. 469 
An investigation into the environmental reservoirs and transmission of these 470 
pathogens is warranted and urgently required. 471 
 472 
Methods 473 
 474 
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Bacterial Isolates 475 
 476 
S. Enteritidis isolates were selected on the basis of six factors; date of original 477 
isolation, antimicrobial susceptibility pattern, geographic site of original isolation, 478 
source (human [invasive vs stool], animal or environmental), phage type (where 479 
available), and multilocus variable number tandem repeat (MLVA) type (where 480 
available). S. Enteritidis P125109 (EMBL accession no. AM933172) isolated from a 481 
poultry farm from the UK was used as a reference [32]. The full metadata are in 482 
Supplementary Table 1. Isolates have been attributed to region according to United 483 
Nations statistical divisions 484 
(http://unstats.un.org/unsd/methods/m49/m49regin.htm). 485 
 486 
Sequencing, SNP-calling, construction of phylogeny and comparative genomics 487 
 488 
PCR libraries were prepared from 500 ng of DNA as previously described [44]. 489 
Isolates were sequenced using Illumina GA II, HiSeq 2000 and MiSeq machines 490 
(Illumina, San Diego, CA, USA) and 150 bp paired-end reads were generated.  The 491 
strains were aligned to Salmonella Enteritidis reference genome P125109 using a 492 
pipeline developed in-house at the Wellcome Trust Sanger Institute (WTSI). For 493 
each isolate sequenced, the raw sequence read pairs were split to reduce the overall 494 
memory usage and allow reads to be aligned using more than one CPU. The reads 495 
were then aligned using SMALT (www.sanger.ac.uk/science/tools/smalt-0), a 496 
hashing based sequence aligner. The aligned and unmapped reads were combined 497 
into a single BAM file. Picard (https://broadinstitute.github.io/picard) was used to 498 
identify and flag optical duplicates generated during the making of a standard 499 
Illumina library, which reduces possible effects of PCR bias. All of the alignments 500 
were created in a standardized manner, with the commands and parameters stored 501 
in the header of each BAM file, allowing for the results to be easily reproduced.  502 
 503 
The combined BAM file for each isolate was used as input data in the SAMtools 504 
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mpileup program to call SNPs and small indels, producing a BCF file describing all of 505 
the variant base positions [45]. A pseudo-genome was constructed by substituting 506 
the base call at each variant or non-variant site, defined in the BCF file, in the 507 
reference genome. Only base calls with a depth of coverage >4 or quality >50 were 508 
considered in this analysis. Base calls in the BCF file failing this quality control filter 509 
were replaced with the "N” character in the pseudo-genome sequence.  510 
  511 
All of the software developed is freely available for download from GitHub under an 512 
open source license, GNU GPL 3.  513 
 514 
Phylogenetic modelling was based on the assumption of a single common ancestor, 515 
therefore variable regions where horizontal genetic transfer occurs were excluded 516 
[46] [47]. A maximum likelihood (ML) phylogenetic tree was then built from the 517 
alignments of the isolates using RAxML (version 7.0.4) using a GTR+I+G model [48]. 518 
The maximum-likelihood phylogeny was supported by 100 bootstrap pseudo-519 
replicate analyses of the alignment data. Clades were predicted using Hierarchical 520 
Bayesian Analysis of Population Structure (HierBAPS)[24]. This process was 521 
repeated to construct the plasmid phylogeny, using reads that aligned to pSENV.   522 
To ascertain the presence of the clusters defined by HierBAPs in the Public Health 523 
England (PHE) routine Salmonella surveillance collection, seventeen isolates 524 
representing the diversity of the collection were compared against 2986 S. 525 
Enteritidis PHE genomes.  Single linkage SNP clustering was performed as 526 
previously described [49].  A maximum-likelihood phylogeny showing the 527 
integration of the seventeen isolates with 50-SNP cluster representatives of the PHE 528 
S. Enteritidis collection was constructed as above.  FASTQ reads from all PHE 529 
sequences in this study can be found at the PHE Pathogens BioProject at the 530 
National Center for Biotechnology Information (Accession PRJNA248792). 531 
 532 
   533 
Temporal reconstruction was performed using Bayesian Evolutionary Analysis 534 
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Sampling Trees (BEAST: http://beast.bio.ed.ac.uk/ version 1.8.2)[50]. A relaxed 535 
lognormal clock model was initially employed. The results of this model indicated 536 
that a constant clock model was not appropriate, as the posterior of the standard 537 
deviation of the clock rate did not include zero. A range of biologically plausible 538 
population models (constant, exponential and skyline) was investigated. Skyline 539 
models can be biased by non-uniform sampling and we observed a strong similarity 540 
between reconstructed skyline population and the histogram of sampling dates and 541 
so this model was excluded. The exponential models consistently failed to converge 542 
and were excluded. Thus, for all datasets, lognormal clock and constant population 543 
size models were used. The computational expense required for this analysis 544 
precluded running estimators for model selection. However, we note that Deng et al 545 
used the same models in their analysis of 125 S. Enteritidis isolates. Default priors 546 
were used except for ucld.mean, Gamma(0.001,1000), initial: 0.0001; 547 
exponential.popSize, LogNormal(10,1.5), initial: 1[21].  548 
 549 
Three chains of 100 million states were run in parallel for each clade of the four 550 
major HierBAPS clades, as well as a fourth chain without genomic data to examine 551 
the influence of the prior, which in all cases was uninformative. The final results, as 552 
used here, all had effective sample sizes (ESS) of over 200 and had convergence 553 
between all three runs. For the Global and Global Outlier lineages, the datasets were 554 
not computationally feasible to analyse. We thus created 3 further random subsets 555 
of the data by drawing n isolates from each sampled year where n was sampled 556 
from a Poisson distribution where λ=2. The posteriors of all subsets were extremely 557 
similar and runs were combined to produce the final most recent common ancestor 558 
(MRCA) estimates. 559 
 560 
In order to gain a detailed insight into genomic differences, a single high quality 561 
sequence from Malawian S. Enteritidis isolate D7795 was aligned against the 562 
P125109 using ABACAS and annotated [51]. Differences were manually curated 563 
against the reference using the Artemis Comparison Tool (ACT)[52]. Sections of 564 
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contigs which were incorporated into the alignment, but which did not align with 565 
P125109 were manually inspected and compared to the public databases using 566 
BLASTn (http://blast.ncbi.nlm.nih.gov). When these regions appeared to be novel 567 
prophages, they were annotated using the phage search tool PHAST and manually 568 
curated [53]. In order to investigate whether the SNPs and/or indels that were 569 
predicted to be responsible for pseudogene formation in D7795 were distinct to that 570 
isolate or conserved across both African epidemic clades, all isolates were aligned to 571 
P12509 and the relevant SNPs/indels investigated using in-silico PCR of the aligned 572 
sequences. Manual curation was performed to confirm the nature of all pseudogene-573 
associated SNPs/indels. NS-SNPs identified in D7795 were sorted throughout the 574 
African clades by extracting and aligning the appropriate gene sequences from 575 
P125109 and D7795. The coordinates of the NS-SNPs were then used to identify the 576 
relevant sequence and determine the nature of the base.  577 
 578 
Accessory genome 579 
The pangenome for the dataset was predicted using ROARY [54]. Genes were 580 
considered to be core to S. Enteritidis if present in ≥90% of isolates. A relaxed 581 
definition of core genome was used as assemblies were used to generate it and the 582 
more assemblies one uses, the more likely it is that a core gene will be missed in one 583 
sample due to an assembly error. The remaining genes were considered to be core 584 
to the clades/clusters predicted by HierBAPS if present in ≥75% if isolates from 585 
within each clade/cluster. These genes were then curated manually using ACT to 586 
search for their presence and position in P125109 or the improved draft assembly 587 
of representative isolates of each of the other clades if not present in P125109. Any 588 
large accessory regions identified were blasted against the assembled genomes of 589 
the entire collection to confirm they were grossly intact. 590 
 591 
Plasmid identification  592 
Plasmid DNA was extracted from isolate D7795 using the Kado & Liu method and 593 
separated by gel-electrophoresis alongside plasmids of known size, to estimate the 594 
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number and size of plasmids present [55]. Plasmid conjugation was attempted by 595 
mixing 100 μL of overnight culture of donor and recipient strains (rifampicin 596 
resistant Escherichia coli C600) on Luria-Bertani agar plates and incubating 597 
overnight at 26°C and 37°C. The plasmid was sequenced using the PacBio platform 598 
(http://www.pacificbiosciences.com/) to gain long reads and a single improved 599 
draft assembly, which was aligned against P125109 plasmid pSENV (Accession 600 
Number HG970000). For novel regions of the plasmid from isolate D7795, genes 601 
were predicted using GLIMMER and manual annotations applied based on 602 
homology searches against the public databases, using both BLASTn and FASTA. The 603 
plasmid phylogeny was reconstructed using the same methodology as the 604 
chromosome; a maximum likelihood (ML) phylogenetic tree was built from the 605 
alignments of the isolates using RAxML (version 7.0.4) using a GTR+I+G model 606 
 607 
Identification of AMR genes 608 
 609 
A manually curated version of the Resfinder database was used to investigate the 610 
isolates for the presence of AMR genes [56]. To reduce redundancy, the database 611 
was clustered using CD-HIT-EST [57], with the alignment length of the shorter 612 
sequence required to be 90% the length of the longer sequence. All other options 613 
were left as the defaults. The representative gene of each cluster was then mapped 614 
with SMALT (http://www.sanger.ac.uk/science/tools/smalt-0) to the assemblies of 615 
each isolate to identify and matches with an identity of 90% or greater were 616 
considered significant, in line with the default clustering parameters of CD-HIT-EST. 617 
Where partial matches were identified at the ends of contigs, having an identity of 618 
90% or greater to the matched region of the gene, potential AMR gene presence was 619 
recorded. To confirm presence of these partial matches, raw sequencing reads of the 620 
pertinent isolates were mapped using SMALT to these genes to check for 90% 621 
identity across the entire gene. 622 
 623 
 624 
22 
 
BiologTM growth substrate platform profiling 625 
 626 
The BiologTM platform (http://www.biolog.com) enables the simultaneous 627 
quantitative measurement of a number of cellular phenotypes, and therefore the 628 
creation of a phenotypic profile of a variety of assay conditions [58]. Incubation and 629 
recording of phenotypic data were performed using an OmniLog® plate reader. In 630 
these experiments, two replicates of D7795 were compared to two of PT4-like strain 631 
A1636 at 28 and 37˚C to represent environmental and human temperatures. 632 
BiologTM plates PM1-4 and 9 (Carbon source [PM1, PM2], nitrogen source [PM3] and 633 
phosphor and sulphur source [PM4] metabolism and osmotic pressure [PM9]) were 634 
used. Each well was inoculated as described in the high throughput phenotyping 635 
protocol, thereby testing 475 conditions at once (each plate has one negative control 636 
well). Plates were scanned every 15 min for 48 hours while incubated at 28°C and 637 
37°C in air. Two paired replicates were performed for each of the two isolates. 638 
 639 
After completion of the run, the signal data were compiled and analysed using the 640 
limma package (www.bioconductor.org) in ‘R’ (www.R-project.org) as described 641 
previously [59]. A log-fold change of 0.5 controlling for a 5% false discovery rate 642 
was used as a cut-off for investigating a specific metabolite further using Pathway 643 
Tools [60] and whether the metabolic change was related to pseudogenes and non 644 
synonymous(NS)-SNPs in genes in the respective genomes. 645 
 646 
In vivo Infection Model 647 
 648 
Two isolates were used in the animal models: S. Enteritidis P125109 and D7795. 649 
Unvaccinated commercial female egg-layer Lohmann Brown chicks (Domestic Fowl 650 
[Gallus gallus]) were obtained from a commercial hatchery and housed in secure 651 
floor pens at a temperature of 25°C. Eight chicks per strain per time point were 652 
inoculated by gavage at 10 days (d) of age and received a dose of ~108 Salmonella 653 
colony forming units (CFU) in a volume of 0.2 mL. Subsequently, four to five birds 654 
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from each group were humanely killed at 3, 7 or 21 d post-infection (p.i.). At post 655 
mortem, the liver, spleen, and caecal contents were removed aseptically, 656 
homogenised, serially diluted and dispensed onto Brilliant Green agar (Oxoid) to 657 
quantify colony forming units (CFU) as described previously [61]. Statistical analysis 658 
was performed using SPSS, version 20 (IBM). Kruskal-Wallis was used to compare 659 
bacterial loads between infected groups. 660 
 661 
All work was conducted in accordance with the UK legislation governing 662 
experimental animals, Animals (Scientific Procedures) Act 1986, under project 663 
licence 40/3652 and was approved by the University of Liverpool ethical review 664 
process prior to the award of the project license.   The licensing procedure requires 665 
power calculations to determine minimal group sizes for each procedure to ensure 666 
results are significant. For these experiments a group size of 8 birds per time point 667 
was chosen, based on a variation in 1.0 log10 in bacterial count between groups as 668 
being significant along with prior experience of Salmonella infection studies. Groups 669 
were randomly selected on receipt from the hatchery and investigators conducting 670 
animal experiments were not blinded, as the current UK code of practice requires all 671 
cages or pens to be fully labeled with experimental details. No animals were 672 
excluded from the analysis.  All animals were checked a minimum of twice daily to 673 
ensure their health and welfare. 674 
 675 
Code availability 676 
 677 
Software is referenced and URLS are provided in the text of the methods, all 678 
software is open source.  679 
  680 
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Tables 897 
Table 1: Summary of metadata (n) by region in numbers  898 
 899 
 900 
*Multidrug resistant: resistant to ≥3 antimicrobials 901 
†Extended spectrum beta lactamase producing 902 
‡Uruguay strains previously characterised by Betancor [62] 903 
  904 
Region Total Site of isolation Antimicrobial resistance 
phenotype 
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Asia 11 5 5 1 0 0 0 0 0 
Europe 61 0 16 24 2 0 0 0 0 
South America 27‡ 3 6 7 8 0 0 0 0 
North Africa 12 9 1 1 9 0 0 2 0 
Sub-Saharan 
Africa 
353 269 22 7 99 64 14
9 
0 3 
Republic of South 
Africa 
131 57 74 0 83 44 4 0 0 
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Table 2: Metadata summarised by clade 905 
 Major 
Clade/cluster 
Site of isolation 
N (%) 
Number (%) of 
antimicrobial 
resistance genes* 
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1
-3
 
4
-6
 
7
-9
 
West African 61 (92) 1 (2) 0 (0) 4 (6) 22 (33) 9 
(14) 
35 (66) 
Central/Eastern 
African 
155 
(93) 
7 (4) 0 (0) 5 (3) 0 (0) 11 
(7) 
156 
(93) 
Global epidemic 94 (38) 95 
(38) 
31 (12) 30 
(12) 
243 
(97) 
7 (3) 0 (0) 
Outlier cluster 51 (38) 36 
(27) 
27 (20) 20 
(15) 
128 
(96) 
3 (2) 3 (2) 
 906 
*All isolates contained cryptic aminoglycoside acetyltransferase gene aac(6’)-ly[26] 907 
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 909 
Figures  910 
 911 
Figure 1: Maximum likelihood phylogeny of S. Enteritidis based on 675 isolates 912 
rooted to S. Gallinarum. There are 3 epidemic clades; 2 African epidemic clades and 913 
a global epidemic clade. Scale bar indicates nucleotide substitutions per site.  914 
 915 
Figure 2: Differences in accessory genomes of 4 major clades. Approximate position 916 
of prophages in chromosome is depicted, although prophages are not drawn to scale 917 
 918 
Figure 3: Heat map revealing changes in metabolic activity of Central/Eastern 919 
African clade isolate D7795 when compared to global epidemic isolate A1636 at 28 920 
and 37˚C. The figure also displays whether there are corresponding mutations in 921 
genes related to the affected metabolic pathway. (NSSNP=Non-synonymous single 922 
nucleotide polymorphism, HDG = Hypothetically disrupted gene) 923 
 924 
Figure 4: Salmonella isolation from a chick infection model demonstrates failure of 925 
Central/Eastern African clade isolate to invade chicken spleen (4A) and liver (4B) or 926 
to colonize chicken caeca (4C) at 7 days post infection (dpi) (n=24 at this time point) 927 
compared to the global epidemic clade. Numbers are expressed as colony forming 928 
units (CFU) per gram of tissue 929 
  930 
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Supplementary Data 931 
 932 
Supplementary Table 1: Metadata associated with each individual strain including 933 
date, place, and source of isolation plus antimicrobial susceptibility data where 934 
known.  Predicted antimicrobial resistance genes are also included 935 
Supplementary Table 2: Full list of predicted antimicrobial resistance genes 936 
Supplementary Table 3: List of pseudogenes identified in D7795 and confirmation of 937 
presence/absence across African clades  938 
Supplementary Table 4: List of genes in both Central/Eastern and West African 939 
clades with non-synonymous SNPs present throughout both clades  940 
Supplementary Table 5: Comparison of genomic degradation seen in African 941 
epidemic clade with that seen in S. Typhi and S. Gallinarum 942 
Supplementary Table 6: Full list of phenotypic differences between an example of 943 
the Central/Eastern African clade (D7795) and an example of the global epidemic 944 
clade (A1636) at 37˚C and corresponding genetic differences 945 
 Supplementary Table 7: Full list of phenotypic differences between an example of 946 
the Central/Eastern African clade (D7795) and an example of the global epidemic 947 
clade (A1636) at 28˚C and corresponding genetic differences 948 
 949 
Supplementary Figure 1: Maximum likelihood phylogeny placing representative 950 
isolates from current study within the context of the diversity of S. Enteritidis 951 
genomes in the PHE collection.  Black taxa labels represent PHE 50-SNP cluster 952 
representatives, red taxa labels represent seventeen representative strains from 953 
this study. 954 
Supplementary Figure 2: Maximum likelihood phylogeny with strains of known 955 
phage type highlighted, demonstrating the lack of genomic diversity captured by 956 
phage typing  957 
Supplementary Figure 3: BEAST tree of Central/Eastern African Clade and West 958 
African Clades revealing estimated age of clades 959 
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Supplementary Figure 4: Histograms of dates and BEAST results (treeHeight) for the 960 
subsets of the outlier cluster (S3A and S3C) and global epidemic clade (S3B and 961 
S3D)  962 
Supplementary Figure 5: Distribution of prophage regions across the isolate 963 
collection highlighted. Red indicates presence, blue absence. Gaps indicate isolates 964 
not sequenced at Sanger Institute 965 
Supplementary Figure 6: Maximum likelihood phylogeny of S. Enteritidis plasmids  966 
 967 
High throughput phenotyping protocol 968 
 969 
Supplementary results 970 
